Chapter 6 - The Shadows of the Legacy
The success of the Charlotte center’s reopening echoed across the medical technology industry, but in the polished, high-society dining rooms of Boston and New York, a bitter storm was brewing.
Inside a private, dimly lit study in an uptown Manhattan brownstone, Harrison Vance poured two fingers of scotch. His hand trembled slightly—not from age, but from a deep, poisonous humiliation. Across from him sat Edward Sterling, the older brother of the disgraced Richard Sterling. Edward was a ruthless venture capitalist who owned a controlling stake in BioDynamic Solutions, Bennett Medical’s fiercest corporate rival.
"Jonathan has lost his mind," Harrison spat, setting the crystal glass down on a marble coaster with a sharp clack. "He’s turned our board into a public relations circus. He’s taking orders from a nineteen-year-old girl who doesn't even hold an associate degree. The market is going to punish us during the Q4 earnings call."
Edward Sterling leaned back in his leather wingback chair, swirling his drink. "The market doesn't care about sentiment, Harrison. The market cares about margins. And right now, Bennett Medical’s margins are bleeding because Jonathan is honoring every legacy claim that my brother wisely buried."
"The federal prosecutors are still digging through Richard’s files," Harrison muttered, his voice dropping to a harsh whisper. "If they find the secondary offshore accounts connected to BioDynamic’s supply contracts, it won't just be Richard going to prison. They'll come for me. They'll come for your board seats."
Edward’s eyes narrowed into cold, calculating slits. "Then we make sure the narrative changes before the prosecutors finish their audit."
"How?" Harrison asked. "Jonathan has secured eighty percent of the voting proxy through his personal trust. We can't vote him out."
"We don't need to vote him out," Edward said smoothly, pulling a thin black tablet from his coat pocket and sliding it across the table. "We destroy the credibility of his miracle intern. If Annie Carter’s diagnostic protocols are proven to be flawed—or worse, manufactured—Jonathan’s entire restructuring falls apart. The board will be forced to appoint an emergency management committee to save the stock from plummeting."
Harrison picked up the tablet. On the screen was a draft of a technical paper set to be published by an independent medical journal the following week. The title read: Biomechanical Vulnerabilities and Algorithmic Failures in Neural-Array Prosthetic Assemblies.
"Is this real?" Harrison asked.
"It will be," Edward smiled, a sinister edge to his voice. "We hired three senior biomechanical consultants from Johns Hopkins to review Annie’s red notebook calculations. They found a minor statistical variance in her thermal expansion equations—a variance we have amplified into a full-scale safety hazard. By Monday morning, every major financial outlet will run stories claiming Bennett Medical’s new 'Junior Director' pushed an unsafe, untested micro-hydraulic system onto the market."
May you like
Harrison looked up, a slow, predatory smile spreading across his face. "And Jonathan’s precious Mark-X Vanguard prototype?"
"The FDA will receive an anonymous petition to suspend the Mark-X clinical trials effective immediately," Edward replied coldly. "Let's see how well Jonathan Bennett's moral crusade holds up when his stock crashes thirty percent in a single morning."
